Gyala, Therapeutics

Gyala Therapeutics initiates Phase I/ IIa clinical trial of a CAR-T cell therapy in acute leukemias with limited treatment options

Veröffentlicht: 19.03.2026 um 22:37 Uhr, prnewswire.co.uk

Gyala Therapeutics United Kingdom Spain United States of America California

View original content:https://www.prnewswire.co.uk/news-releases/gyala-therapeutics-initiates-phase-iiia-clinical-trial-of-a-car-t-cell-therapy-in-acute-leukemias-with-limited-treatment-options-302681402.html

en | boerse | 68904738 |